EP2906696
METHODS FOR MODULATING C9ORF72 EXPRESSION
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
15.10.2013EP published:
9.10.2019EP application number:
13846313.8
EPO information:
European Patent Register
Max expiry date:
14.10.2033
Title:
METHODS FOR MODULATING C9ORF72 EXPRESSION
Timeline
Today
15.10.2013EP application
9.10.2019EP Publication
Owner
Name:
Ionis Pharmaceuticals, Inc.Address:
2855 Gazelle Court, 92010, Carlsbad, CA, US
Name:
Ludwig Institute for Cancer ResearchAddress:
666 Third Avenue, 10017, New York, NY, US
Name:
The Regents of the University of CaliforniaAddress:
1111 Franklin Street, 5th Floor, 94607-5200, Oakland, CA, US
Inventor
Name:
RIGO, FrankAddress:
Carlsbad, CA, ES
Name:
CLEVELAND, Don W.Address:
La Jolla, CA, US
Name:
LAGIER-TOURENNE, ClotildeAddress:
La Jolla, CA, US
Name:
RAVITS, John M.Address:
San Francisco, CA, US
Name:
BENNETT, C. FrankAddress:
Carlsbad, CA, US
Name:
FREIER, SUSAN M.Address:
Carlsbad, CA, US
Name:
BAUGHN, Michael W.Address:
La Jolla, CA, US
Priority
Number:
201261714139 PDate:
15.10.2012Country:
US
Classification
Categories:
C12N 15/113, A61P 25/28